Aroldo Rossi

2.1k total citations
30 papers, 1.4k citations indexed

About

Aroldo Rossi is a scholar working on Neurology, Physiology and Rheumatology. According to data from OpenAlex, Aroldo Rossi has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 8 papers in Physiology and 7 papers in Rheumatology. Recurrent topics in Aroldo Rossi's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Aroldo Rossi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Neurological disorders and treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Aroldo Rossi collaborates with scholars based in Italy, United Arab Emirates and Saudi Arabia. Aroldo Rossi's co-authors include Paolo Calabresi, Nicola Tambasco, Lucilla Parnetti, Paolo Eusebi, Davide Chiasserini, Claudia De Carlo, Alfredo Berardelli, Laura Pierguidi, Antonella Giannantoni and Massimo Porena and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and The Journal of Urology.

In The Last Decade

Aroldo Rossi

29 papers receiving 1.3k citations

Peers

Aroldo Rossi
Matthew S. Ripsch United States
Sonia K. Bhangoo United States
W. Poewe Germany
Sandy Zhang-Nunes United States
Paul J. Spira Australia
Aroldo Rossi
Citations per year, relative to Aroldo Rossi Aroldo Rossi (= 1×) peers Alex Incensi

Countries citing papers authored by Aroldo Rossi

Since Specialization
Citations

This map shows the geographic impact of Aroldo Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aroldo Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aroldo Rossi more than expected).

Fields of papers citing papers by Aroldo Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aroldo Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aroldo Rossi. The network helps show where Aroldo Rossi may publish in the future.

Co-authorship network of co-authors of Aroldo Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Aroldo Rossi. A scholar is included among the top collaborators of Aroldo Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aroldo Rossi. Aroldo Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parnetti, Lucilla, Lucia Farotti, Paolo Eusebi, et al.. (2014). Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. Frontiers in Aging Neuroscience. 6. 53–53. 139 indexed citations
2.
Tambasco, Nicola, Vincenzo Belcastro, Paolo Prontera, et al.. (2014). Shapiro's syndrome: Defining the clinical spectrum of the spontaneous paroxysmal hypothermia syndrome. European Journal of Paediatric Neurology. 18(4). 453–457. 20 indexed citations
3.
Tambasco, Nicola, P Chiarini, R. Tarducci, et al.. (2014). Entacapone Reduces Cortical Activation in Parkinson's Disease with Wearing-Off: A f-MRI Study. PLoS ONE. 9(5). e96806–e96806. 12 indexed citations
4.
Caproni, Stefano, Domenico Frondizi, Giuseppe Capocchi, et al.. (2013). Complexity of Motor Sequences and Cortical Reorganization in Parkinson's Disease: A Functional MRI Study. PLoS ONE. 8(6). e66834–e66834. 23 indexed citations
5.
Tambasco, Nicola, Simone Simoni, E Marsili, et al.. (2012). Clinical Aspects and Management of Levodopa-Induced Dyskinesia. Parkinson s Disease. 2012. 1–12. 23 indexed citations
6.
Maremmani, Carlo, Giuseppe Rossi, Nicola Tambasco, et al.. (2012). The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson's disease patients. Parkinsonism & Related Disorders. 18(6). 788–793. 26 indexed citations
7.
Castrioto, Anna, Paolo Prontera, Eleonora Di Gregorio, et al.. (2011). A novel spinocerebellar ataxia type 15 family with involuntary movements and cognitive decline. European Journal of Neurology. 18(10). 1263–1265. 16 indexed citations
8.
Conte, Antonella, Antonella Giannantoni, Silvia Proietti, et al.. (2011). Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. European Journal of Neurology. 19(5). 725–732. 24 indexed citations
9.
Parnetti, Lucilla, Davide Chiasserini, Gianni Bellomo, et al.. (2011). Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias. Movement Disorders. 26(8). 1428–1435. 143 indexed citations
10.
Parnetti, Lucilla, Laura Pierguidi, Cataldo D’Amore, et al.. (2009). Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. Neurobiology of Disease. 34(3). 484–486. 54 indexed citations
11.
Belcastro, Vincenzo, Laura Pierguidi, Anna Castrioto, et al.. (2009). Hyperhomocysteinemia recurrence in levodopa‐treated Parkinson’s disease patients. European Journal of Neurology. 17(5). 661–665. 11 indexed citations
12.
Belcastro, Vincenzo, Lucilla Parnetti, Paolo Prontera, et al.. (2008). Hot water epilepsy and Mccune–Albright syndrome: A case report. Seizure. 18(2). 161–162. 2 indexed citations
13.
Filippo, Massimiliano Di, Barbara Picconi, Alessandro Tozzi, et al.. (2008). The Endocannabinoid System in Parkinsons Disease. Current Pharmaceutical Design. 14(23). 2337–2346. 42 indexed citations
14.
Caccamo, Daniela, Gaetano Gorgone, Monica Currò, et al.. (2007). Effect of MTHFR Polymorphisms on Hyperhomocysteinemia in Levodopa-treated Parkinsonian Patients. NeuroMolecular Medicine. 9(3). 249–254. 27 indexed citations
15.
Michiara, Maria, Laura Pierguidi, Emanuele Persichetti, et al.. (2007). Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease. Movement Disorders. 22(10). 1481–1484. 96 indexed citations
16.
Tambasco, Nicola, Francesco Corea, Giorgio Silvestrelli, et al.. (2006). Multimodal Use of Computed Tomography in Early Acute Stroke, Part 1. Clinical and Experimental Hypertension. 28(3-4). 421–426. 1 indexed citations
17.
Bazzichi, L., Aroldo Rossi, Floriana Giorgio, et al.. (2003). Clinical improvement in systemic sclerosis resulting from urokinase therapy explained by light and electron microscopy skin examination. Scandinavian Journal of Rheumatology. 32(5). 261–267. 2 indexed citations
18.
Costanzi, Eva, et al.. (1999). Elevated β-N-acetylhexosaminidase activity in focal dystonia fibroblasts. Clinica Chimica Acta. 288(1-2). 31–35. 2 indexed citations
19.
Defazio, Giovanni, Alfredo Berardelli, Giovanni Abbruzzese, et al.. (1998). Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. Journal of Neurology Neurosurgery & Psychiatry. 64(1). 25–32. 87 indexed citations
20.
Capocchi, Giuseppe, et al.. (1987). Creatine kinase BB activity in serum of patients with acute stroke: correlation with the severity of brain damage. Neurological Sciences. 8(6). 567–570. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026